Orion Infusions Limited, a pharmaceutical and chemicals sector company listed on the stock exchange, topped the trading list last week. The company’s contribution to the total turnover on the Dhaka Stock Exchange (DSE) during the week was 6.89%.

On the last trading day, the company’s share price rose by 8.73%, or BDT 25.70, reaching BDT 320.20 per share, with the closing price matching the day’s highest. Throughout the day, the share price fluctuated between BDT 299.90 and BDT 320.20. A total of 530,700 shares changed hands in 2,803 transactions, amounting to BDT 16.88 crore. Over the past year, the company’s share price has ranged between BDT 217.20 and BDT 726.90.

Orion Infusions, which became publicly listed in 1994, currently holds an ‘A’ category status. The company’s authorized capital is BDT 100 crore, with paid-up capital of BDT 20.36 crore and reserves of BDT 8.76 crore. Of the total 20,359,760 shares, 40.61% are held by entrepreneurs and directors, 5.21% by institutional investors, 0.05% by foreign investors, and the remaining 54.13% by the general public.

For the fiscal year ending June 30, 2024, Orion Infusions declared a 12% cash dividend, with earnings per share (EPS) of BDT 2.08. The net asset value (NAV) per share was BDT 15.45, and the net cash flow per share was BDT 2.82. For the previous year, 2023, the company declared a 10% cash dividend, with an EPS of BDT 2.06 and a NAV of BDT 14.32.

In 2022, Orion Infusions paid a 20% cash dividend, with an EPS of BDT 2.10, and a NAV of BDT 14.22. The company’s cash flow per share for that year was BDT 2.23. In 2021, the company had given a 10% cash dividend, with an EPS of BDT 1.37 and a NAV of BDT 13.10.

Other companies contributing significantly to the trading volume included Dragon Sweater and Spinning Ltd (2.60%), Asiatic Laboratories Ltd (2.38%), Tawfiq Foods and Lavello Ice Cream PLC (2.25%), Sayham Cotton Mills Ltd (2.18%), NRB Bank PLC (2.12%), Beximco Pharmaceuticals Ltd (2.03%), Bangladesh Shipping Corporation (1.58%), Zenex Infosys Ltd (1.55%), and Square Pharmaceuticals Ltd (1.54%).